Review Ascites-Derived Organoids: Emerging Models for Drug Resistance and Personalized Therapy Full text PDF
Research Paper Integrative Multi-Cohort and Single-Cell Analyses Identify KIF11 as a Prognostic and Immune-Cold Marker in Lung Adenocarcinoma Full text PDF
Research Paper Co-targeting Aurora Kinase A and DNA Damage Response Pathways Enhances Apoptotic Cell Death in Cholangiocarcinoma Cells Full text PDF
Review Lung Cancer Evolves as an Ecosystem from Niche Dysregulation to Metastasis and Treatment Resistance Full text PDF
Review The Roles of Vitamins in Cancer Initiation, Progression, and Therapy: Clinical Evidence, Molecular Mechanisms, and Precision Translation Full text PDF
Research Paper Real-World Experience with Neoadjuvant Treatment for Stage I-III Non-Small Cell Lung Cancer: A Single-Center Cohort Study and TriNetX database Full text PDF
Issue 11; 2026
Indexed in PubMed and SCI expanded; full texts in Europe PMC. ...
Ascites-Derived Organoids: Emerging Models for Drug Resistance and Personalized Therapy
Traditional two-dimensional cell models and animal models struggle to replicate tumor heterogeneity and microenvironment interactions. Existing treatments have low efficiency, high recurrence rates and no personalized regimens. Malignant Ascites-Derived Organoids (MADOs), three-dimensional models constructed from tumor cells isolated from malignant ascites, can highly preserve the histological features, molecular expression profiles, genomic landscapes, ...
Lung adenocarcinoma (LUAD) is characterized by substantial molecular heterogeneity and marked differences in clinical outcome and therapeutic response. Although the mechanical microenvironment contributes to tumor progression and immune regulation, the prognostic and immunological relevance of mechanobiology-related genes in LUAD remains incompletely understood. In this study, we integrated transcriptomic, clinical, genomic, immunotherapy, and single-cell ...